Cargando…

Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study

OBJECTIVES: Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral drug being used to treat influenza in Russia and China. This study aimed to investigate the effectiveness and safety of umifenovir for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lian, N., Xie, H., Lin, S., Huang, J., Zhao, J., Lin, Q.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182750/ https://www.ncbi.nlm.nih.gov/pubmed/32344167 http://dx.doi.org/10.1016/j.cmi.2020.04.026

Ejemplares similares

Antioxidant Potential of Antiviral Drug Umifenovir
por: Proskurnina, Elena V., et al.
Publicado: (2020)

Reinforcing the supply chain of umifenovir and other antiviral drugs with retrosynthetic software
por: Lin, Yingfu, et al.
Publicado: (2021)

Effect of umifenovir (arbidol) versus standard care on clinical outcome in patients with COVID-19: a retrospective cohort study
por: Yi, Wanwan, et al.
Publicado: (2023)

Moxifloxacin/umifenovir: Pancytopenia and off label use: case report
Publicado: (2021)

Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
por: Nojomi, Marzieh, et al.
Publicado: (2020)

Author Correction: Reinforcing the supply chain of umifenovir and other antiviral drugs with retrosynthetic software
por: Lin, Yingfu, et al.
Publicado: (2022)

Lopinavir/ritonavir/umifenovir: Nausea, vomiting and diarrhoea following off-label treatment: case report
Publicado: (2021)

Umifenovir Epigenetically Targets the IL-10 Pathway in Therapy against Coxsackievirus B4 Infection
por: Zhang, Shilin, et al.
Publicado: (2022)

Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
por: Leneva, Irina, et al.
Publicado: (2021)

Immune globulin/umifenovir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Moxifloxacin/umifenovir: Lack of efficacy following off-label use: case report
Publicado: (2021)

Methylprednisolone/umifenovir interaction: Sinus bradycardia and off label use: case report
Publicado: (2022)

Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial
por: Alavi Darazam, Ilad, et al.
Publicado: (2021)

Meropenem/moxifloxacin/umifenovir: QT interval prolongation and off label use: 2 case reports
Publicado: (2021)

Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
por: Amani, Behnam, et al.
Publicado: (2021)

Association of Statin Use With the In-Hospital Outcomes of 2019-Coronavirus Disease Patients: A Retrospective Study
por: Fan, Yongzhen, et al.
Publicado: (2020)

Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019
por: Haidar, Ghady, et al.
Publicado: (2021)

Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
por: Haviernik, Jan, et al.
Publicado: (2018)

Antiviral drug Umifenovir (Arbidol) in municipal wastewater during the COVID-19 pandemic: Estimated levels and transformation
por: Ul'yanovskii, Nikolay V., et al.
Publicado: (2022)

Revisiting the Solubility–Permeability Relationship with Hydrophobic Drug Umifenovir in Pluronic Solutions: Impact of pH and Co-Solvent
por: Volkova, Tatyana, et al.
Publicado: (2023)

Retrospective analysis of clinical features in 134 coronavirus disease 2019 cases
por: Zhang, Lin, et al.
Publicado: (2020)

Coronavirus disease 2019 vaccination and infertility treatment outcomes
por: Avraham, Sarit, et al.
Publicado: (2022)

Coronavirus Disease 2019
por: Lin, Sophie, et al.
Publicado: (2021)

Chloroquine/lopinavir/ritonavir/umifenovir: QTc interval prolongation, drug interaction and off-label use: 2 case reports
Publicado: (2020)

Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes
por: Peng, Hui, et al.
Publicado: (2020)

Coronavirus disease 2019 and cardiovascular disease
por: Song, Jenn-Yeu, et al.
Publicado: (2023)

Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019
por: yang, Hui, et al.
Publicado: (2020)

Risk Factors of Coronavirus Disease 2019-Related Mortality and Optimal Treatment Regimens: A Retrospective Study
por: Wang, Yuehong, et al.
Publicado: (2021)

Coronavirus disease 2019 in pregnant and non-pregnant women: a retrospective study
por: Zha, Ying, et al.
Publicado: (2021)

Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019
por: Yang, Qiuxiang, et al.
Publicado: (2020)

Coronavirus 2019 disease: Are corticosteroids the key treatment? A retrospective case-control study in Brazil
por: Rios, Salete S., et al.
Publicado: (2022)

Thoracic surgery outcomes for patients with Coronavirus Disease 2019
por: Chang, Stephanie H., et al.
Publicado: (2021)

Novel coronavirus disease 2019 and perinatal outcomes
por: Irani, Morvarid, et al.
Publicado: (2020)

The chest CT features of coronavirus disease 2019 (COVID-19) in China: a meta-analysis of 19 retrospective studies
por: Yang, Haitao, et al.
Publicado: (2020)

The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes
por: Tang, Guoxing, et al.
Publicado: (2021)

Coronavirus Disease 2019–Associated Coagulopathy
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Dupilumab Use Is Associated With Protection From Coronavirus Disease 2019 Mortality: A Retrospective Analysis
por: Donlan, Alexandra N, et al.
Publicado: (2022)

Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China
por: Lei, Chunliang, et al.
Publicado: (2020)

The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study
por: Chung, Seung Min, et al.
Publicado: (2020)

Clinical Characteristics and Outcomes of Severe and Critical Patients With 2019 Novel Coronavirus Disease (COVID-19) in Wenzhou: A Retrospective Study
por: Qian, Song-Zan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_35e2pt4ajlvdncdi50sca61r76